Abstract
Cyclophosphamide, a drug that has not previously had an important role in whole-organ transplantation, was given as a primary immunosuppressant to one liver and eleven kidney recipients, in combination with prednisone and horse antilymphocyte globulin. One of the patients died despite good renal-graft function. Two kidneys from a common cadaveric donor failed. The other nine patients have excellent function of their homografts after 2-3 months. Cyclophosphamide was substituted for azathioprine in one hepatic and five renal recipients who were suspected of having liver toxicity from azathioprine 3 months to almost 8 years post-transplantation. Graft function was maintained after this change, and the evidence of liver injury subsided.
Original language | English (US) |
---|---|
Pages (from-to) | 70-74 |
Number of pages | 5 |
Journal | The Lancet |
Volume | 298 |
Issue number | 7715 |
DOIs | |
State | Published - Jul 10 1971 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine